AnalyzeDirect Thoene-Reineke C, Rumschüssel K, Schmerbach K, Krikov M, Wengenmayer C, Godes M, Mueller S, Villringer A, Steckelings U, Namsolleck P, Unger T. Prevention and intervention studies with telmisartan, ramipril and their combination in different rat stroke models. PLoS One. August 2011;6(8):e23646.
Full Text – Open Access
Publication Date
August 2011
How Analyze was Used
“Calculation of lesion volume was carried out with the program Analyze 5.0 (AnalyzeDirect, Inc.; Lenexa [Kansas] USA) [Garcia et al. 1995, Schmerbach 2008] (Figure 3 C).”
Keywords
Animals
Antihypertensive Agents/therapeutic use
Benzimidazoles/therapeutic use
Benzoates/therapeutic use
Male
Ramipril/therapeutic use
Random Allocation
Rats
Rats, Inbred SHR
Rats, Wistar
Stroke/drug therapy/prevention & control
Author Affiliation(s)
Center for Cardiovascular Research (CCR)/Institute of Pharmacology, Charité – Universitätsmedizin Berlin, Berlin, Germany. (CTR, KR, KS, MK, CW, MG, US, PN, TU)
Forschungseinrichtung für Experimentelle Medizin, Charité – Universitätsmedizin Berlin, Berlin, Germany. (CTR)
Center for Stroke Research Berlin, Charité – Universitätsmedizin Berlin, Berlin, Germany. (SM)
MPI für Kognitions- und Neurowissenschaften, Leipzig, Germany. (AV)
ID# 849
Tags: Animals, Antihypertensive Agents/therapeutic use, Benzimidazoles/therapeutic use, Benzoates/therapeutic use, Inbred SHR Rats, Male, Ramipril/therapeutic use, Random Allocation, Rats, Stroke/drug therapy/prevention & control, Wistar Rats